Should You Use Compression During a Lymphedema Attack?
At a Glance
No, you should not use compression therapy during an acute lymphedema attack. If your limb becomes red, hot, and painful, remove compression garments immediately. Continuing compression can spread the bacterial infection. Rest completely and contact a doctor for prescription antibiotics.
No, if you have lymphedema caused by lymphatic filariasis, you should not wear compression bandages or garments during an acute attack (often called an ADLA flare-up). If you are experiencing a painful, red, and hot flare-up, you must remove your tight compression bandages immediately [1]. During this active infection phase, compression therapy, elevation, and exercise must be stopped right away [2][3]. Continuing to use these methods can make the local inflammation worse, increase your pain, and potentially cause the bacterial infection to spread throughout your body [1][4].
What to Do During an Acute Flare-Up
An acute attack (acute dermatolymphangioadenitis or ADLA) is typically caused by a bacterial infection in the skin and lymphatic vessels [5][2]. When you have signs of an active attack—such as fever, red skin, and a limb that feels hot to the touch—your priority must shift from managing your chronic swelling to treating the urgent infection [1][6].
Instead of using your normal compression routine, follow these steps:
- Stop your routine: Immediately pause the use of compression bandages or garments, stop elevating the limb, and halt any exercise or manual lymphatic drainage (MLD) routines [2][1]. Like compression, elevation and exercise can alter circulation in a way that may encourage the infection to spread while the limb is actively inflamed [4].
- Rest: Complete rest is critical during the acute phase to help your body fight the infection [6][7].
- Seek medical treatment: Contact your doctor right away. Acute attacks require prescription antibiotics to clear the underlying bacterial infection [8][9]. Your doctor may also recommend pain relievers and fever-reducing medications (like acetaminophen) to help manage your symptoms, rather than NSAIDs which can sometimes mask the signs of a worsening infection [1][7]. If you experience “red flag” symptoms like rapidly spreading redness, severe chills, vomiting, or confusion, seek emergency care immediately.
When to Resume Compression
You should only resume compression therapy, elevation, and exercise after the acute infection has fully cleared [10][11].
You will know the infection is resolving when the acute symptoms—such as fever, local pain, and redness—have completely faded [10][12]. Wait until your doctor confirms that the bacterial infection is gone before restarting your normal lymphedema management routine [13][14]. Once the attack has passed, returning to your regular compression and hygiene routine is essential, as this helps reduce the frequency and severity of future infections [15][16].
Common questions in this guide
Should I wear my compression garment if my lymphedema limb is red and hot?
What should I do during an acute lymphedema flare-up?
What medications can help during a sudden lymphedema attack?
When is it safe to restart compression therapy after an infection?
Questions for Your Doctor
4 questions
- •What specific signs indicate that my infection has cleared enough to safely restart compression therapy?
- •Should I keep an emergency prescription of antibiotics on hand for future flare-ups?
- •Which over-the-counter pain relievers are safest for me to use during an active lymphatic infection?
- •How should I clean and care for my skin during the days I cannot wear my compression garments?
Questions for You
3 questions
- •What early warning signs (like a sudden fever or a specific kind of pain) usually happen right before my limb turns red and hot?
- •Do I have a reliable way to contact my doctor or access urgent care if a flare-up starts over the weekend?
- •Are there any small cuts or fungal infections on my feet that might have allowed bacteria to enter?
References
References (16)
- 1
Clinical evaluation of AYUSH-SL in patients receiving mass drug administration for treatment of chronic inflammatory lymphedema: A doubleblind placebo-controlled multicentric study.
Mitra A, Bhuyan G, Muralikrishna C, et al.
Journal of vector borne diseases 2025; (62(2)):202-210 doi:10.4103/JVBD.JVBD_61_24.
PMID: 39636260 - 2
Bacterial diversity significantly reduces toward the late stages among filarial lymphedema patients in the Ahanta West District of Ghana: A cross-sectional study.
Asiedu SO, Kini P, Aglomasa BC, et al.
Health science reports 2022; (5(4)):e724 doi:10.1002/hsr2.724.
PMID: 35873398 - 3
Comparative analysis of skin microbiome of patients with filarial lymphedema and healthy individuals.
Manavalan S, Pradeep D, Dharmalingam D, et al.
PloS one 2025; (20(7)):e0325380 doi:10.1371/journal.pone.0325380.
PMID: 40601568 - 4
Antibiotic resistance and mecA characterization of Staphylococcus hominis from filarial lymphedema patients in the Ahanta West District, Ghana: A cross-sectional study.
Kini P, Wireko S, Osei-Poku P, et al.
Health science reports 2023; (6(2)):e1104 doi:10.1002/hsr2.1104.
PMID: 36778776 - 5
Unveiling Facklamia: detection of an emerging microbe in the skin microbiome of patients with filarial lymphedema.
Dharmalingam D, Semalaiyappan J, Thirumal S, Kuttiatt VS
Frontiers in cellular and infection microbiology 2025; (15()):1624288 doi:10.3389/fcimb.2025.1624288.
PMID: 40822586 - 6
Health beliefs and health seeking behavior towards lymphatic filariasis morbidity management and disability prevention services in Luangwa District, Zambia: Community and provider perspectives.
Maritim P, Silumbwe A, Zulu JM, et al.
PLoS neglected tropical diseases 2021; (15(2)):e0009075 doi:10.1371/journal.pntd.0009075.
PMID: 33617551 - 7
Global Preventive and Management Strategies and Their Effectiveness in Patients With Secondary Lymphedema: A Scoping Review.
Mwesigye V, Atwine D, Munguciada EF, et al.
Cureus 2025; (17(5)):e83627 doi:10.7759/cureus.83627.
PMID: 40486300 - 8
Antimicrobial susceptibility of bacteria isolated from the infected wounds of patients with lymphoedema in East Wollega, Ethiopia.
Nigussie D, Makonnen E, Legesse BA, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2020; (114(12)):962-973 doi:10.1093/trstmh/traa143.
PMID: 33247921 - 9
Exploring the Antibacterial, Antioxidant and Larvicidal Effects against Culex quinquefasciatus of Nigella sativa Seeds and its Silver Nanoparticles.
Jebaseelan J, Ganesh UK, Johnwilmet PL, et al.
Acta parasitologica 2025; (70(4)):164 doi:10.1007/s11686-025-01096-x.
PMID: 40690073 - 10
Clinical features, microbiological epidemiology and recommendations for management of cellulitis in extremity lymphedema.
Rodriguez JR, Hsieh F, Huang CT, et al.
Journal of surgical oncology 2020; (121(1)):25-36 doi:10.1002/jso.25525.
PMID: 31264724 - 11
Ultrasonography as an instrument to evaluate lymphedema secondary to breast cancer: systematic review.
de Rezende LF, Piloni JPM, Kempa VL, et al.
Jornal vascular brasileiro 2023; (22()):e20220144 doi:10.1590/1677-5449.202201441.
PMID: 38162983 - 12
Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.
Stillwaggon E, Sawers L, Rout J, et al.
The American journal of tropical medicine and hygiene 2016; (95(4)):877-884 doi:10.4269/ajtmh.16-0286.
PMID: 27573626 - 13
Cost-effectiveness and social outcomes of a community-based treatment for podoconiosis lymphoedema in the East Gojjam zone, Ethiopia.
Hounsome N, Kassahun MM, Ngari M, et al.
PLoS neglected tropical diseases 2019; (13(10)):e0007780 doi:10.1371/journal.pntd.0007780.
PMID: 31644556 - 14
Fluid Shifts Induced by Physical Therapy in Lower Limb Lymphedema Patients.
Brix B, Apich G, Roessler A, et al.
Journal of clinical medicine 2020; (9(11)) doi:10.3390/jcm9113678.
PMID: 33207688 - 15
Risk factors of recurrent erysipelas in adult Chinese patients: a prospective cohort study.
Li A, Wang N, Ge L, et al.
BMC infectious diseases 2021; (21(1)):26 doi:10.1186/s12879-020-05710-3.
PMID: 33413190 - 16
Comorbidities as Risk Factors for Acute and Recurrent Erysipelas.
Brishkoska-Boshkovski V, Kondova-Topuzovska I, Damevska K, Petrov A
Open access Macedonian journal of medical sciences 2019; (7(6)):937-942 doi:10.3889/oamjms.2019.214.
PMID: 30976336
This page provides educational information about managing acute lymphedema attacks. Always consult your healthcare provider or seek emergency care immediately for sudden infections, fevers, or rapidly spreading redness.
Get notified when new evidence is published on Lymphatic filariasis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.